Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SHPCX vs. FBDIX: which is better?

Bottom line

SHPCX vs FBDIX: the short answer

SHPCX (Health & Biotechnology Portfolio) and FBDIX (Franklin Biotechnology Discovery Fund) are both mutual funds.

But FBDIX is far broader, holding 126 positions to 29 for SHPCX, so beyond the top names it adds exposure SHPCX doesn't have.

FBDIX is cheaper at 1.01% vs 3.6% — a difference of $259 a year per $10,000 invested.

Over five years, FBDIX returned +5.0% a year vs +3.7% for SHPCX (reporting dates differ).

FBDIX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

SHPCX vs FBDIX side by side

SHPCXFBDIX
TypeMutual fundMutual fund
Fund familySaratoga AdvantageFranklin Templeton
CategoryTechnology SectorTechnology Sector
Expense ratio3.6%1.01%
Annual cost per $10k$360$101
10-yr cost on $10k (prospectus)$3,862$1,728
Max front load0%5.5%
12b-1 fee—0.25%
1-yr return−1.3%+43.9%
5-yr return (annualized)+3.7%+5.0%
10-yr return (annualized)+4.1%+6.4%
Best quarter+15.0%+29.5%
Worst quarter−13.0%−24.5%
Net assets (fund)$10.5M$1.2B
Number of holdings29126
Portfolio turnover22%38%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearSHPCXFBDIXDifference
2024−0.3%+4.0%−4.3%
2023−0.9%+18.4%−19.3%
2022+1.4%−12.7%+14.1%
2021+16.0%−17.7%+33.7%
2020+3.0%+29.9%−26.9%
2019+15.4%+34.8%−19.4%
2018−6.0%−15.7%+9.7%
2017+11.3%+18.8%−7.6%
2016−2.5%−17.2%+14.7%
2015+6.3%+5.5%+0.8%

Source: Fund prospectus bar charts

Holdings overlap

5 of SHPCX's top 25 holdings also appear in FBDIX's top 25.

Shared top holdings
HoldingSHPCXFBDIX
Amgen Inc5.04%4.39%
Gilead Sciences Inc3.94%3.86%
Regeneron Pharmaceuticals Inc3.93%3.77%
Vertex Pharmaceuticals Inc3.36%3.54%
Eli Lilly & Company2.11%1.31%

Source: SEC Form N-PORT

SHPCX top 10

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. United Therapeutics Corp — 6.17%
  4. Amgen Inc — 5.04%
  5. Mckesson Corp — 4.90%
  6. Lantheus Holdings Inc — 4.64%
  7. Exelixis Inc — 4.55%
  8. Novartis Ag — 4.50%
  9. Cencora Inc — 4.33%
  10. Gilead Sciences Inc — 3.94%

FBDIX top 10

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Revolution Medicines, Inc. — 3.01%
  9. Guardant Health, Inc. — 2.76%
  10. Ascendis Pharma A/S — 2.56%

FAQ

What is the difference between SHPCX and FBDIX?
SHPCX (Health & Biotechnology Portfolio) and FBDIX (Franklin Biotechnology Discovery Fund) are both mutual funds. But FBDIX is far broader, holding 126 positions to 29 for SHPCX, so beyond the top names it adds exposure SHPCX doesn't have.
Which is cheaper, SHPCX or FBDIX?
FBDIX has the lower expense ratio (1.01%).
Should I own both SHPCX and FBDIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.